Iron-Targeting Antitumor Activity of Gallium Compounds and Novel Insights Into Triapine®-Metal Complexes

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Antioxidants and Redox Signaling

• Publication date

  2013-01-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1089/ars.2012.4880PMID 22900955PMCID PMC3557436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bortezomib in the treatment of mantle cell lymphoma.

  2015cited by this paper
• Rapid Publication Gallium Nitrate Inhibits Calcium Resorption from Bone and Is Effective Treatment for Cancer-related Hypercalcemia

  2013cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• The Potent and Novel Thiosemicarbazone Chelators Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone and 2-Benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone Affect Crucial Thiol Systems Required for Ribonucleotide Reductase Activity

  2011cited by this paper
• The iron-chelating drug triapine causes pronounced mitochondrial thiol redox stress.

  2011cited by this paper
• Interaction of Triapine and related thiosemicarbazones with iron(III)/(II) and gallium(III): a comparative solution equilibrium study.

  2011cited by this paper
• Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes.

  2011cited by this paper
• Cytotoxicity, apoptosis and study of the DNA-binding properties of bi- and tetranuclear gallium(III) complexes with heterocyclic thiolato ligands

  2011cited by this paper
• An iron regulatory gene signature predicts outcome in breast cancer.

  2011cited by this paper
• Organogallium(III) complexes as apoptosis promoting anticancer agents for head and neck squamous cell carcinoma (HNSCC) cell lines.

  2011cited by this paper
• Mitochondrial Mayhem: The Mitochondrion as a Modulator of Iron Metabolism and Its Role in Disease

  2011cited by this paper
• Synthesis and structure-activity evaluation of isatin-β-thiosemicarbazones with improved selective activity toward multidrug-resistant cells expressing P-glycoprotein.

  2011influential reference
• Hepatocellular carcinoma detection by gallium scan and subsequent treatment by gallium maltolate: rationale and case study.

  2011cited by this paper
• A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo.

  2011influential reference
• Cytotoxic Evaluation of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, 3-AP, in Peripheral Blood Lymphocytes of Patients with Refractory Solid Tumors using Electron Paramagnetic Resonance.

  2011cited by this paper
• Ironing out cancer.

  2011cited by this paper
• Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): a combined experimental and theoretical study.

  2011influential reference
• Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity.

  2010cited by this paper
• Ferroportin and iron regulation in breast cancer progression and prognosis.

  2010cited by this paper
• Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies

  2010cited by this paper
• A novel gallium compound synergistically enhances bortezomib-induced apoptosis in mantle cell lymphoma cells.

  2010cited by this paper
• Two to tango: regulation of Mammalian iron metabolism.

  2010cited by this paper
• Synthesis, Structure, and Antiproliferative Activity of Three Gallium(III) Azole Complexes

  2010cited by this paper
• Anticancer activity of dinuclear gallium(III) carboxylate complexes.

  2010cited by this paper
• Targeting metabolic transformation for cancer therapy

  2010cited by this paper
• Novel gallium(III) complexes containing phthaloyl derivatives of neutral aminoacids with apoptotic activity in cancer cells

  2009cited by this paper
• Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors.

  2009influential reference
• Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen

  2009cited by this paper
• Gallium(III) complexes of 2-pyridineformamide thiosemicarbazones: cytotoxic activity against malignant glioblastoma.

  2009cited by this paper
• Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation.

  2009cited by this paper
• 2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.

  2009influential reference
• Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine.

  2008cited by this paper
• Role of oxidative stress in the induction of metallothionein-2A and heme oxygenase-1 gene expression by the antineoplastic agent gallium nitrate in human lymphoma cells.

  2008cited by this paper
• Initial phase I clinical and pharmacokinetic assessment of G4544, an oral gallium-containing compound

  2008cited by this paper
• Complex I within Oxidatively Stressed Bovine Heart Mitochondria Is Glutathionylated on Cys-531 and Cys-704 of the 75-kDa Subunit

  2008cited by this paper
• An electrochemical study of antineoplastic gallium, iron and ruthenium complexes with redox noninnocent alpha-N-heterocyclic chalcogensemicarbazones.

  2008cited by this paper
• Bortezomib for the Treatment of Mantle Cell Lymphoma

  2007cited by this paper
• Development of Gallium Compounds for Treatment of Lymphoma: Gallium Maltolate, a Novel Hydroxypyrone Gallium Compound, Induces Apoptosis and Circumvents Lymphoma Cell Resistance to Gallium Nitrate

  2007cited by this paper
• Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects.

  2007influential reference
• Tuning Cell Cycle Regulation with an Iron Key

  2007cited by this paper
• Gallium(III) and iron(III) complexes of alpha-N-heterocyclic thiosemicarbazones: synthesis, characterization, cytotoxicity, and interaction with ribonucleotide reductase.

  2007cited by this paper
• Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia.

  2007cited by this paper
• Gene expression analysis of gallium-resistant and gallium-sensitive lymphoma cells reveals a role for metal-responsive transcription factor-1, metallothionein-2A, and zinc transporter-1 in modulating the antineoplastic activity of gallium nitrate

  2007cited by this paper
• Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity.

  2006cited by this paper
• Resistance to the Antineoplastic Agent Gallium Nitrate Results in Marked Alterations in Intracellular Iron and Gallium Trafficking: Identification of Novel Intermediates

  2006cited by this paper
• Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins.

  2006cited by this paper
• A Ferrous-triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase

  2006cited by this paper
• Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma.

  2006cited by this paper
• Chelators at the Cancer Coalface: Desferrioxamine to Triapine and Beyond

  2006cited by this paper
• Gallium-induced cell death in lymphoma: role of transferrin receptor cycling, involvement of Bax and the mitochondria, and effects of proteasome inhibition

  2006cited by this paper
• Prognostic significance of metallothionein in B-cell lymphomas.

  2006cited by this paper
• A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics

  2006cited by this paper
• Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.

  2006cited by this paper
• Synthesis, structure, and anticancer activity of gallium(III) complexes with asymmetric tridentate ligands: growth inhibition and apoptosis induction of cisplatin-resistant neuroblastoma cells.

  2006cited by this paper
• Proteasome inhibitor therapy in multiple myeloma

  2005cited by this paper
• Early results from a phase I study on orally administered tris(8-quinolinolato)gallium(III) (FFC11, KP46) in patients with solid tumors--a CESAR study (Central European Society for Anticancer Drug Research--EWIV).

  2005cited by this paper
• Gallium compounds as antineoplastic agents

  2004cited by this paper
• Glutaredoxin 2 Catalyzes the Reversible Oxidation and Glutathionylation of Mitochondrial Membrane Thiol Proteins

  2004cited by this paper
• Gallium nitrate for the treatment of non-Hodgkin’s lymphoma

  2004cited by this paper
• Phase 2 Multicenter Trial of Gallium Nitrate in Patients with Advanced Non-Hodgkin’s Lymphoma (NHL).

  2004cited by this paper
• Intralysosomal iron: a major determinant of oxidant-induced cell death.

  2003cited by this paper
• Gallium nitrate in the treatment of lymphoma.

  2003cited by this paper
• Expression of the hemochromatosis (HFE) gene modulates the cellular uptake of 67Ga.

  2003cited by this paper
• Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.

  2003cited by this paper
• The effects of gallium nitrate on bone resorption.

  2003cited by this paper
• Gallium nitrate in the treatment of bladder cancer.

  2003cited by this paper
• Treatment of cancer-related hypercalcemia: the role of gallium nitrate.

  2003cited by this paper
• Synthesis, structure, spectroscopic and in vitro antitumour studies of a novel gallium(III) complex with 2-acetylpyridine (4)N-dimethylthiosemicarbazone.

  2002cited by this paper
• Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.

  2001cited by this paper
• Cellular adaptation to down-regulated iron transport into lymphoid leukaemic cells: effects on the expression of the gene for ribonucleotide reductase.

  2000cited by this paper
• Metallothionein expression in animals: a physiological perspective on function.

  2000cited by this paper
• Chemistry and Pharmacokinetics of Gallium Maltolate, a Compound With High Oral Gallium Bioavailability

  2000cited by this paper
• Iron homeostasis: new tales from the crypt.

  2000cited by this paper
• The Hereditary Hemochromatosis Protein, HFE, Specifically Regulates Transferrin-mediated Iron Uptake in HeLa Cells*

  1999cited by this paper
• Metallothionein: an intracellular protein to protect against cadmium toxicity.

  1999cited by this paper
• Microtubule-disrupting effects of gallium chloride in vitro.

  1999cited by this paper
• Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): an inhibitor of ribonucleotide reductase with antineoplastic activity.

  1999cited by this paper
• Mechanisms of therapeutic activity for gallium.

  1998cited by this paper
• Transferrin receptor-dependent and -independent iron transport in gallium-resistant human lymphoid leukemic cells.

  1998cited by this paper
• Gallium-pyridoxal isonicotinoyl hydrazone (Ga-PIH), a novel cytotoxic gallium complex. A comparative study with gallium nitrate.

  1998cited by this paper
• Global prevalence of putative haemochromatosis mutations.

  1997cited by this paper
• Vinblastine, ifosfamide, and gallium nitrate—an active new regimen in patients with advanced carcinoma of the urothelium

  1997cited by this paper
• Evaluation of continuous-infusion gallium nitrate and hydroxyurea in combination for the treatment of refractory non-Hodgkin's lymphoma.

  1997cited by this paper
• Preclinical toxicology and tissue gallium distribution of a novel antitumour gallium compound: tris (8-quinolinolato) gallium (III).

  1996cited by this paper
• Copper radionuclides and radiopharmaceuticals in nuclear medicine.

  1996cited by this paper
• Evaluation of transferrin and gallium-pyridoxal isonicotinoyl hydrazone as potential therapeutic agents to overcome lymphoid leukemic cell resistance to gallium nitrate.

  1996cited by this paper
• The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.

  1995cited by this paper
• Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma.

  1994cited by this paper
• Synergistic inhibition of T-lymphoblastic leukemic CCRF-CEM cell growth by gallium and recombinant human alpha-interferon through action on cellular iron uptake.

  1994cited by this paper
• Synergism of taxol and gallium nitrate in human breast carcinoma cells: schedule dependency.

  1994cited by this paper
• Inhibition of protein tyrosine phosphatase by the antitumor agent gallium nitrate.

  1993cited by this paper
• Modulation of transferrin receptor mRNA by transferrin-gallium in human myeloid HL60 and lymphoid CCRF-CEM leukaemic cells.

  1993cited by this paper
• Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators.

  1993cited by this paper
• Treatment with gallium nitrate: Evidence for interference with iron metabolism in vivo

  1992cited by this paper
• Effect of gallium on the tyrosyl radical of the iron-dependent M2 subunit of ribonucleotide reductase.

  1992cited by this paper
• Regulatory effects of gallium on transferrin-independent iron uptake by human leukemic HL60 cells.

  1992cited by this paper
• Gallium Nitrate

  1991cited by this paper
• Inhibition of iron uptake in HL60 cells by 2-formylpyridine monothiosemicarbazonato Cu(II).

  1991cited by this paper
• Gallium nitrate. A review of its pharmacological properties and therapeutic potential in cancer related hypercalcaemia.

  1991cited by this paper
• Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors

  1991cited by this paper

• Implementing the design cues of dissociation dynamics and transmetalation in gallium(iii) complexes to promote the anti-proliferative activity of ligands targeting intracellular iron(ii) trafficking.

  2026cites this paper
• The emerging potential of gallium compounds in medical research: A promising frontier.

  2025cites this paper
• Some Biological Applications and Mechanistic Insights of Benzaldehyde‐Substituted Thiosemicarbazones and Their Metal Complexes: A Review

  2025cites this paper
• Lysosome as a Chemical Reactor

  2025cites this paper
• Transmetalation in Cancer Pharmacology

  2025cites this paper
• Antimicrobial Activity of Gallium(III) Compounds: Pathogen-Dependent Targeting of Multiple Iron/Heme-Dependent Biological Processes

  2024cites this paper
• Bis(thiosemicarbazide)gallium(III) Complexes as Potent Anticancer Agents by ROS Induction and Mitochondrial Pathway Activation

  2024cites this paper
• Gallium complex K6 inhibits colorectal cancer by increasing ROS levels to induce DNA damage and enhance phosphatase and tensin homolog activity

  2024cites this paper
• Synthesis, Characterization, and Cytotoxicity of a Ga(III) Complex with Warfarin

  2024cites this paper
• Survey of Main Group Metals and Metalloids in Cancer Treatment

  2024cites this paper
• In Vivo Trafficking of the Anticancer Drug Tris(8-Quinolinolato) Gallium (III) (KP46) by Gallium-68/67 PET/SPECT Imaging

  2023cites this paper
• Recent Trends in the Development of Novel Metal-Based Antineoplastic Drugs

  2023cites this paper
• (8-Hydroxyquinoline) Gallium(III) Complex with High Antineoplastic Efficacy for Treating Colon Cancer via Multiple Mechanisms

  2023cites this paper
• Deferoxamine Inhibits Acute Lymphoblastic Leukemia Progression through Repression of ROS/HIF-1α, Wnt/β-Catenin, and p38MAPK/ERK Pathways

  2022cites this paper
• Pyridoxal hydrochloride thiosemicarbazones with copper ions inhibit cell division via Topo-I and Topo-IIɑ.

  2022cites this paper
• Synergic role of zinc and gallium doping in hydroxyapatite nanoparticles to improve osteogenesis and antibacterial activity.

  2022cites this paper
• Rationale for Tailoring an Alternative Oncology Trial Using a Novel Gallium-Based Nanocomplex: Mechanistic Insights and Preclinical Challenges

  2022cites this paper
• Comparative evaluation of the structure and antitumor mechanism of mononuclear and trinucleated thiosemicarbazone Cu(II) complexes.

  2022cites this paper
• Synthesis, crystal structures and anti-cancer mechanism of Cu(II) complex derived from 2-acetylpyrazine thiosemicarbazone

  2022cites this paper
• Cerium and gallium containing mesoporous bioactive glass nanoparticles for bone regeneration: Bioactivity, biocompatibility and antibacterial activity.

  2021cites this paper
• Relation of Metal-Binding Property and Selective Toxicity of 8-Hydroxyquinoline Derived Mannich Bases Targeting Multidrug Resistant Cancer Cells

  2021cites this paper
• Design and Synthesis of Novel Betulin Derivatives Containing Thio-/Semicarbazone Moieties as Apoptotic Inducers through Mitochindria-Related Pathways

  2021cites this paper
• Versatile delivery systems for non-platinum metal-based anticancer therapeutic agents

  2021cites this paper
• Single-crystal structure and intracellular localization of Zn(II)-thiosemicarbazone complex targeting mitochondrial apoptosis pathways.

  2020cites this paper
• THERAPEUTIC APPLICATIONS OF GALLIUM COMPOUNDS

  2020cites this paper
• Synthesis, crystal structure and antiproliferative mechanisms of gallium(iii) complexes with benzoylpyridine thiosemicarbazones

  2020cites this paper
• GALLIUM NANOPARTICLES AS DELIVERY SYSTEM AGAINST INFECTIOUS DISEASES AND CANCER

  2020cites this paper
• In Vitro Interaction of 5-Aminoorotic Acid and Its Gallium(III) Complex with Superoxide Radical, Generated by Two Model Systems

  2020cites this paper
• Competition between abiogenic and biogenic metal cations in biological systems: Mechanisms of gallium's anticancer and antibacterial effect.

  2020cites this paper
• Methods for assessing cytochrome c oxidase inhibitors and potential antidotes

  2019cites this paper
• Synthesis, anticancer activity and mechanism of iron chelator derived from 2,6-diacetylpyridine bis(acylhydrazones).

  2019cites this paper
• Structure-activity relationships of 2‑quinolinecarboxaldehyde thiosemicarbazone gallium(III) complexes with potent and selective anticancer activity.

  2019cites this paper
• Concentration of Fe(3+)-Triapine in BEAS-2B Cells

  2019cites this paper
• Novel Insights Into Gallium's Mechanism of Therapeutic Action: a DFT/PCM Study of the Interaction Between Ga3+ and Ribonucleotide Reductase Substrates.

  2019cites this paper
• Mechanisms of cyanide and azide binding to cobalt complexes relevant to their antidotal action

  2018cites this paper
• Anticancer redox activity of gallium nanoparticles accompanied with low dose of gamma radiation in female mice

  2018cites this paper
• A Comparison of the Cyanide-Scavenging Capabilities of Some Cobalt-Containing Complexes in Mice.

  2018cites this paper
• Synthesis, antiproliferative activity and mechanism of gallium(III)-thiosemicarbazone complexes as potential anti-breast cancer agents.

  2018cites this paper
• Gallium(III) complexes of α-N-heterocyclic piperidylthiosemicarbazones: Synthesis, structure-activity relationship, cellular uptake and activation of caspases-3/7/9.

  2018cites this paper
• Indium/Gallium Maltolate Effects on Human Breast Carcinoma Cells: In Vitro Investigation on Cytotoxicity and Synergism with Mitoxantrone

  2018cites this paper
• Effects of Deferoxamine on Leukemia In Vitro and Its Related Mechanism

  2018cites this paper
• Piperidylthiosemicarbazones Cu(II) complexes with a high anticancer activity by catalyzing hydrogen peroxide to degrade DNA and promote apoptosis.

  2018cites this paper
• Gallium(III)–2-benzoylpyridine-thiosemicarbazone complexes promote apoptosis through Ca2+ signaling and ROS-mediated mitochondrial pathways

  2018cites this paper
• Novel 2-pyridinecarboxaldehyde thiosemicarbazones Ga(III) complexes with a high antiproliferative activity by promoting apoptosis and inhibiting cell cycle.

  2017cites this paper
• Synthesis, crystal structure and antiproliferative mechanisms of 2-acetylpyridine-thiosemicarbazones Ga(III) with a greater selectivity against tumor cells.

  2017cites this paper
• Complex formation reactions of gallium(III) and iron(III/II) with l-proline-thiosemicarbazone hybrids: A comparative study

  2017cites this paper
• LC–MS/MS assay for the quantitation of the ribonucleotide reductase inhibitor triapine in human plasma

  2017cites this paper
• High Borate Networks as a Platform to Modulate Temporal Release of Therapeutic Metal Ions Gallium and Strontium

  2017cites this paper
• Anticancer Agents Beyond Cisplatin

  2017cites this paper
• An overview on Ga-68 radiopharmaceuticals for positron emission tomography applications

  2016cites this paper
• Synergistic efficacy of γ-radiation together with gallium trichloride and/or doxorubicin against Ehrlich carcinoma in female mice

  2016cites this paper
• Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism

  2016cites this paper
• Gallium maltolate inhibits human cutaneous T-cell lymphoma tumor development in mice.

  2015cites this paper
• Novel p 53-dependent anticancer strategy by targeting iron signaling and BNIP 3 L-induced mitophagy

  2015cites this paper
• Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy

  2015cites this paper
• Coordination compounds in cancer: Past, present and perspectives

  2015cites this paper
• Gallium and Gallium Semiconductor Compounds

  2015cites this paper
• Applying the Fe(III) binding property of a chemical transferrin mimetic to Ti(IV) anticancer drug design.

  2014cites this paper
• Palladium(II) and Platinum(II) Complexes Containing Six‐Membered N‐Heterocyclic Ligands: Synthesis, Characterization, Interaction with DNA, DFT Calculation, and Cytotoxicity

  2014cites this paper
• Synthesis, characterization, crystal structure and antimicrobial activity of copper(II) complexes with a thiosemicarbazone derived from 3-formyl-6-methylchromone

  2014cites this paper
• Cancer Biology and Signal Transduction Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP 46

  2014cites this paper
• Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP46

  2014cites this paper
• Bio-effects of non-ionizing electromagnetic fields in context of cancer therapy.

  2014cites this paper
• Next-generation metal anticancer complexes: multitargeting via redox modulation.

  2013cites this paper
• Current World Literature

  2013cites this paper
• Redox activation of Fe(III)-thiosemicarbazones and Fe(III)-bleomycin by thioredoxin reductase: specificity of enzymatic redox centers and analysis of reactive species formation by ESR spin trapping.

  2013cites this paper